Target intelligence / Profile preview

SCAN domain-containing protein 1 (SCAND1)

Target
SCAND1
Molecular classification
Transcription factor, Other (domain-only protein, lacks zinc finger motif)
01

Overview

SCAN domain-containing protein 1 (SCAND1) is a protein coded by the SCAND1 gene located on chromosome 20. It possesses an isolated, conserved protein–protein interaction domain (the SCAN box) but lacks the zinc finger domain typical of most SCAN family proteins. SCAND1 functions as a transcriptional regulator by heterodimerizing with full-length SCAN domain transcription factors like myeloid zinc finger 1 (MZF1), modulating their activity and the broader regulatory landscape of gene expression. Functionally, SCAND1 suppresses epithelial-to-mesenchymal transition and can inhibit proliferation and migration in cancer cells, particularly prostate cancer, where it acts as a tumor suppressor and is associated with favorable patient outcomes[1][3][4][5]. These properties make it a potential biomarker and candidate therapeutic target in oncology, although no direct pharmacological modulators are currently known.

Other names
SCAND1RAZ1SDP1SCAN domain containing 1SCAN domain-containing protein 1SCAN-related protein RAZ1
02

Mechanism of action

no approved drugs; mechanism would likely involve modulation of transcriptional regulation or EMT if targeted

03

Biological functions

Regulation of transcriptional activityProtein–protein interaction via SCAN domainModulation of epithelial-to-mesenchymal transition (EMT)Suppression of cell proliferation and migration in cancer
04

Disease associations

CancerHemoglobin D diseaseDominant beta-thalassemiaIRIDA syndromeOverhydrated hereditary stomatocytosisHemoglobin C-beta-thalassemia syndromeSideroblastic anemia 3Dehydrated hereditary stomatocytosisHemolytic anemia due to erythrocyte adenosine deaminase overproductionCryohydrocytosis
05

Safety considerations

no direct data available; theoretical concerns would relate to interference with basic transcriptional regulation and epigenetic states
06

Biomarkers

SCAND1 expression is associated with better prognosis in several cancers, notably prostate cancer

Beyond the preview

Go deeper on SCAN domain-containing protein 1 (SCAND1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCAN domain-containing protein 1 (SCAND1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call